
Solventum: Healthcare Innovation Powerhouse
Solventum emerged in April 2024 as an independent healthcare innovation leader, spinning off from 3M with a bold mission to revolutionize patient care through breakthrough solutions. Headquartered in Saint Paul, Minnesota, this dynamic company employs over 20,000 professionals across 38 countries, generating approximately $8.2 billion in revenue while operating more than 300 global facilities that serve healthcare providers worldwide.
Innovation At the Intersection of Science
Operating through four strategic divisions-MedSurg, Dental Solutions, Health Information Systems, and Purification & Filtration-Solventum delivers cutting-edge products that merge health, material, and data sciences. From advanced wound care solutions and iconic Littmann stethoscopes to sophisticated health information systems and biopharmaceutical purification technologies, the company's comprehensive portfolio addresses critical healthcare challenges with scientific precision and compassionate purpose.
Culture Rooted In Purpose
Five core values guide every initiative: Put people first, Win with excellence, Solve what matters, Advance together, and Live with heart. This distinctive approach combines cutting-edge technology with empathy and compassion, creating an environment where healthcare professionals can pursue meaningful careers while contributing to humanity's advancement.
Career Growth and Development
- Multi-year growth strategy creating new opportunities across diverse healthcare sectors
- Strong commitment to sustainability and social impact initiatives
- Global presence with opportunities in North America, Europe, and emerging markets
- Leadership focused on maximizing brand portfolio potential and employee development
- Work environment that prioritizes both professional excellence and personal fulfillment
Making a Meaningful Impact
Under CEO Bryan Hanson's leadership, Solventum recognizes that 80-90% of health outcomes stem from social determinants of health, driving the company's commitment to addressing global health inequalities. Team members join a culture where innovation directly improves patient lives while advancing healthcare sustainability. Every scientific advancement pursued melds the latest technology with compassion, ensuring solutions that change lives for the better.
Mission
Enabling better, smarter, safer healthcare to improve lives.
Frequently Asked Questions
Jobs for Solventum in United States
Solventum$21.61/hr57006 Brookings, SD
Solventum$35.08/hr57006 Brookings, SD
Solventum$24.39/hr57006 Brookings, SD
Solventum$21.29/hr - $24.24/hr65201 Columbia, MO
Solventum$38.99/hr08822 Flemington, NJ
Solventum$34.48/hr65201 Columbia, MO
Solventum$47.7K/yr - $58.3K/yr21075 Elkridge, MD
Solventum$41.1K/yr - $50.2K/yr68102 Omaha, NE
Solventum$61.9K/yr - $75.7K/yr99216 Spokane Valley, WA
Solventum$43.9K/yr - $53.7K/yr23219 Richmond, VA
Solventum$48.6K/yr - $59.4K/yr11735 East Farmingdale, NY
Solventum$21.61/hr57006 Brookings, SD
Solventum$67.9K/yr - $82.9K/yr96701 Aiea, HI

Description
Solventum Completes Acquisition of Acera Surgical
Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space in acute care settings in the U.S. Accelerates Solventum's business transformation through the acquisition of a strategically aligned asset in a technology adjacency ST. PAUL, Minn., Dec. 23, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today it has completed the acquisition of Acera Surgical (Acera), a privately held bioscience company focused on developing and commercializing fully engineered...
Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy
New guidance highlights evolving surgical procedure applications of reticulated open cell foam (ROCF) dressings to support patient safety, surgical outcomes and future standards of care Solventum(TM) Prevena(TM) Therapy is the only closed incision negative pressure therapy system with fully integrated linear and area dressings solely indicated for closed incisions that utilize ROCF technology ST. PAUL, Minn., Dec. 17, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today announced the consensus...
Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength
ST. PAUL, Minn., Dec. 16, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that it has achieved the Diamond Level Resiliency Badge from the Healthcare Industry Resilience Collaborative (HIRC), the highest recognition for supply chain strength in healthcare. This certification validates Solventum's MedSurg segment's ability to deliver critical healthcare products consistently, even during supply disruptions to help ensure uninterrupted patient care. "The Diamond Level Resiliency...
Solventum to Participate in the 2025 Piper Sandler Healthcare Conference
ST. PAUL, Minn., Nov. 25, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Piper Sandler Healthcare Conference on Tuesday, Dec. 2, 2025, beginning at approximately 10:00 a.m. EST in New York, NY. A live and archived replay of the fireside chat will be available on the company's website at investors.solventum.com. About Solventum At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company...
Solventum Announces Agreement to Acquire Acera Surgical
Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space, a part of the broader regenerative tissue matrices category within acute care settings, a $900 million market segment in the U.S. Accelerates Solventum's business transformation through the acquisition of a strategically aligned asset in a technology adjacency ST. PAUL, Minn., Nov. 20, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today it has entered into a definitive agreement to acquire...

Terumo Medical Corporation

CONMED Corporation

Orchid Orthopedic Solutions

Optum

Medasource

Abbott

Lilly

EVERSANA

Eli Lilly and Company

Curative
